Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $94.75 Consensus Target Price from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has received an average recommendation of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $94.75.

ACHC has been the topic of several recent analyst reports. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, March 5th. UBS Group raised their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Finally, Stephens upgraded shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price target for the company in a research report on Friday, January 5th.

Insiders Place Their Bets

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of ACHC. Vanguard Group Inc. grew its position in shares of Acadia Healthcare by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock valued at $689,065,000 after buying an additional 30,296 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of Acadia Healthcare by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock worth $529,991,000 after acquiring an additional 152,783 shares during the period. William Blair Investment Management LLC lifted its stake in shares of Acadia Healthcare by 0.3% in the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock worth $215,072,000 after acquiring an additional 10,062 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Acadia Healthcare by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock worth $88,482,000 after acquiring an additional 13,765 shares during the period. Finally, Avidity Partners Management LP lifted its stake in Acadia Healthcare by 61.8% during the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock valued at $89,944,000 after purchasing an additional 441,692 shares during the last quarter.

Acadia Healthcare Stock Up 0.7 %

NASDAQ:ACHC opened at $70.74 on Friday. The stock has a market capitalization of $6.54 billion, a price-to-earnings ratio of -282.95, a price-to-earnings-growth ratio of 2.07 and a beta of 1.31. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare has a 52 week low of $66.49 and a 52 week high of $87.77. The stock’s fifty day moving average is $78.68 and its two-hundred day moving average is $77.72.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the firm earned $0.70 earnings per share. Research analysts anticipate that Acadia Healthcare will post 3.57 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.